Tower Research Capital LLC (Trc) Pliant Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,729 shares of PLRX stock, worth $21,301. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,729

Previous 7,689 77.51%

Holding current value

$21,301

Previous $82,000 76.83%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.52 - $14.35 $62,699 - $85,526	-5,960 Reduced 77.51%	1,729 $19,000
Q2 2024 Aug 13, 2024	BUY	$10.58 - $15.61 $73,837 - $108,942	6,979 Added 982.96%	7,689 $82,000
Q1 2024 May 15, 2024	SELL	$14.14 - $19.59 $194,184 - $269,029	-13,733 Reduced 95.08%	710 $10,000
Q4 2023 Feb 13, 2024	BUY	$12.85 - $19.15 $67,758 - $100,977	5,273 Added 57.5%	14,443 $261,000
Q3 2023 Nov 14, 2023	BUY	$14.58 - $20.15 $97,992 - $135,428	6,721 Added 274.44%	9,170 $159,000
Q2 2023 Aug 14, 2023	BUY	$18.12 - $30.56 $32,434 - $54,702	1,790 Added 271.62%	2,449 $44,000
Q1 2023 May 09, 2023	SELL	$18.73 - $36.26 $18,280 - $35,389	-976 Reduced 59.69%	659 $17,000
Q4 2022 Feb 10, 2023	SELL	$17.0 - $25.43 $64,209 - $96,049	-3,777 Reduced 69.79%	1,635 $32,000
Q3 2022 Nov 10, 2022	BUY	$7.67 - $24.23 $17,556 - $55,462	2,289 Added 73.29%	5,412 $113,000
Q2 2022 Aug 15, 2022	BUY	$4.11 - $8.75 $3,505 - $7,463	853 Added 37.58%	3,123 $25,000
Q1 2022 May 12, 2022	BUY	$7.01 - $14.1 $4,486 - $9,024	640 Added 39.26%	2,270 $16,000
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.26 $11,325 - $16,853	923 Added 130.55%	1,630 $22,000
Q3 2021 Nov 15, 2021	SELL	$16.48 - $28.98 $14,568 - $25,618	-884 Reduced 55.56%	707 $11,000
Q2 2021 Aug 16, 2021	BUY	$28.05 - $37.69 $953 - $1,281	34 Added 2.18%	1,591 $46,000
Q1 2021 May 17, 2021	BUY	$24.52 - $40.23 $7,478 - $12,270	305 Added 24.36%	1,557 $61,000
Q4 2020 Feb 16, 2021	SELL	$19.89 - $32.99 $63,110 - $104,677	-3,173 Reduced 71.71%	1,252 $29,000
Q3 2020 Nov 16, 2020	BUY	$21.54 - $29.53 $95,314 - $130,670	4,425 New	4,425 $100,000

Others Institutions Holding PLRX

# of Institutions

168

Shares Held

63.2M

Call Options Held

245K

Put Options Held

373K

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Pliant Therapeutics, Inc. Transaction History